Skip to main content

Introduction to Modern Cancer Diagnosis and Survivorship

  • Chapter
  • First Online:
Orofacial Supportive Care in Cancer

Abstract

This chapter gives the reader an overview of cancer diagnosis and what it means to be a cancer survivor. It also briefly explains the future and challenges in supportive care in cancer in the era of precision oncology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. Bray F, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  Google Scholar 

  2. AACR 2018 Annual Report.

    Google Scholar 

  3. Ahn J, et al. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23:399–404.

    Article  Google Scholar 

  4. Islami F, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31–54.

    Article  Google Scholar 

  5. Gapstur SM, et al. A blueprint for the primary prevention of cancer: targeting established, modifiable risk factors. CA Cancer J Clin. 2018;68:446–70.

    Article  Google Scholar 

  6. Jamal A, et al. Current cigarette smoking among adults—United States 2016. MMWR Morb Mortal Wkly Rep. 2018;67:53–9.

    Article  Google Scholar 

  7. Neri A, et al. Radon control activities for lung cancer prevention in National Comprehensive Cancer Control Program Plans, 2005–2011. Prevent Chronic Dis. 2013;10:120337.

    Article  Google Scholar 

  8. Lehmann U, Bartels S. Liquid biopsy in tumor diagnostics. Pathologe. 2019; https://doi.org/10.1007/s00292-019-0604-5.

  9. Stobiecka M, Ratajczak K, Jakiela S. Toward early cancer detection: focus on biosensing systems and biosensors for an anti-apoptotic protein survivin and survivin mRNA. Biosens Bioelectron. 2019;137:58–71. https://doi.org/10.1016/j.bios.2019.04.060. [Epub ahead of print].

    Article  PubMed  Google Scholar 

  10. Hung KF, et al. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder. Oral Oncol. 2016;53:42–7.

    Article  Google Scholar 

  11. Sharma DC. Salivary bacteria linked to oral cancers. Lancet Oncol. 2005;6:547.

    Article  Google Scholar 

  12. Herrero R, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772–83.

    Article  Google Scholar 

  13. Sohrabi M, Nair RG, Samaranayake LP, et al. The yield and quality of cellular and bacterial DNA extracts from human oral rinse samples are variably affected by the cell lysis methodology. J Microbiol Methods. 2016;122:64–72.

    Article  Google Scholar 

  14. Fadhil RS, Wei MQ, Nikolarakos D, Good D, Nair RG. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic biomarkers for head and neck squamous cell carcinoma. PLoS One. 2020;15(3):e0221779. https://doi.org/10.1371/journal.pone.0221779. eCollection 2020.

  15. Fadhil R, Nair RG, Nikolarakos D, Wei M. Next Generation Sequencing Identifies Novel Diagnostic Biomarkers for Head and Neck Squamous Cell Carcinoma. Oral Cancer. 2019; https://doi.org/10.1007/s41548-019-00019-5.

  16. Tsimberidou AM, et al. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.

    Article  Google Scholar 

  17. Al-Samadi A, et al. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients. Exp Cell Res. 2019;383:111508.

    Article  Google Scholar 

  18. Wang Y, et al. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck carcinomas. Sci Transl Med. 2015;7:293ra104.

    PubMed  PubMed Central  Google Scholar 

  19. Nor JE, Gutkind JS. Head and Neck Cancer in the new era of precision medicine. J Dent Res. 2018;97:601–2.

    Article  Google Scholar 

  20. Agrawal N, et al. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science. 2011;333:1154–7.

    Article  Google Scholar 

  21. Polverini PJ, et al. Precision therapy of head and neck squamous cell carcinoma. J Dent Res. 2018;97:614–21.

    Article  Google Scholar 

  22. Bachour P, Sonis ST. Predicting the risk of mucositis associated with cytotoxic cancer treatment regimens: rationale, complexity and challenges. Curr Opin Support Palliat Care. 2018;12:1998–210.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Raj Nair .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nair, R., Nair, R., Sonis, S.T. (2022). Introduction to Modern Cancer Diagnosis and Survivorship. In: Nair, R. (eds) Orofacial Supportive Care in Cancer . Springer, Cham. https://doi.org/10.1007/978-3-030-86510-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-86510-8_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-86509-2

  • Online ISBN: 978-3-030-86510-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics